V

Vital Healthcare Property Trust
NZX:VHP

Watchlist Manager
Vital Healthcare Property Trust
NZX:VHP
Watchlist
Price: 1.82 NZD -0.55%
Market Cap: 1.2B NZD
Have any thoughts about
Vital Healthcare Property Trust?
Write Note
Section:
 

Relative Value

The Relative Value of one VHP stock under the Base Case scenario is 3.9 NZD. Compared to the current market price of 1.82 NZD, Vital Healthcare Property Trust is Undervalued by 53%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

VHP Relative Value
Base Case
3.9 NZD
Undervaluation 53%
Relative Value
Price
V
Worst Case
Base Case
Best Case

Valuation Multiples

7.2
P/S
P/S
Price to Sales
7.2
vs History
84
vs Industry
25
Median 3Y
9.2
Median 5Y
9.6
Industry
3.6
Forward
8.1
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
31
Median 3Y
4.6
Median 5Y
5.6
Industry
16.7
Forward
17.2
More Details
19.9
P/OCF
P/OCF
Price to OCF
19.9
vs History
71
vs Industry
16
Median 3Y
22.3
Median 5Y
25.5
Industry
10.9
More Details
9.4
P/FCFE
P/FCFE
Price to FCFE
9.4
vs History
36
vs Industry
32
Median 3Y
7.5
Median 5Y
7.7
Industry
13.3
More Details
0.7
P/B
P/B
Price to Book Value
0.7
vs History
79
vs Industry
53
Median 3Y
0.8
Median 5Y
0.9
Industry
0.8
More Details
14.8
EV/S
EV/S
Enterprise Value to Sales
14.8
vs History
74
vs Industry
16
Median 3Y
15.9
Median 5Y
16
Industry
6.6
Forward
16.5
More Details
20.9
EV/GP
EV/GP
Enterprise Value to Gross Profit
20.9
vs History
52
vs Industry
27
Median 3Y
22.1
Median 5Y
22.1
Industry
11.9
More Details
21.9
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
21.9
vs History
80
vs Industry
21
Median 3Y
25.9
Median 5Y
26.2
Industry
15.8
Forward
19.6
More Details
21.9
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
21.9
vs History
80
vs Industry
31
Median 3Y
25.9
Median 5Y
26.2
Industry
19
Forward
19.5
More Details
40.8
EV/OCF
EV/OCF
Enterprise Value to OCF
40.8
vs History
36
vs Industry
12
Median 3Y
41.5
Median 5Y
41.3
Industry
18.5
More Details
49.3
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
49.3
vs History
15
vs Industry
8
Median 3Y
-11.2
Median 5Y
-11.4
Industry
20.1
More Details
0.8
EV/IC
EV/IC
Enterprise Value to IC
0.8
vs History
65
vs Industry
43
Median 3Y
0.8
Median 5Y
0.8
Industry
0.7
More Details

Multiples Across Competitors

VHP Competitors Multiples
Vital Healthcare Property Trust Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
NZ
Vital Healthcare Property Trust
NZX:VHP
1.2B NZD 7.2 -11.4 21.9 21.9
US
Welltower Inc
NYSE:WELL
77.9B USD 10.4 84.8 33.1 79.3
US
Ventas Inc
NYSE:VTR
24.5B USD 5.1 -368.3 17.7 52.1
US
Physicians Realty Trust
NYSE:DOC
14.1B USD 5.5 45.7 14.4 38.2
US
Healthpeak Properties Inc
F:HC5
13.4B EUR 5.5 45.4 14.4 38.1
US
Omega Healthcare Investors Inc
NYSE:OHI
10.2B USD 10.1 29.2 16.4 24.8
US
Healthcare Realty Trust Inc
NYSE:HR
6.4B USD 4.7 -22.6 14.5 210.5
US
Healthcare Trust Of America Inc
F:HT01
5.3B EUR 7.1 58.8 18.6 47.7
US
CareTrust REIT Inc
NYSE:CTRE
4.6B USD 17.2 47 20.2 26.5
US
Sabra Health Care REIT Inc
NASDAQ:SBRA
4B USD 5.8 40.7 15.4 26.1
US
National Health Investors Inc
NYSE:NHI
3B USD 9.1 23.7 16.1 22.2
P/E Multiple
Earnings Growth P/E to Growth
NZ
V
Vital Healthcare Property Trust
NZX:VHP
Average P/E: 46.9
Negative Multiple: -11.4 		N/A N/A
US
Welltower Inc
NYSE:WELL
84.8
309%
0.3
US
Ventas Inc
NYSE:VTR
Negative Multiple: -368.3 N/A N/A
US
Physicians Realty Trust
NYSE:DOC
45.7
-37%
N/A
US
H
Healthpeak Properties Inc
F:HC5
45.4
-37%
N/A
US
Omega Healthcare Investors Inc
NYSE:OHI
29.2
85%
0.3
US
Healthcare Realty Trust Inc
NYSE:HR
Negative Multiple: -22.6 N/A N/A
US
H
Healthcare Trust Of America Inc
F:HT01
58.8
N/A N/A
US
C
CareTrust REIT Inc
NYSE:CTRE
47
417%
0.1
US
Sabra Health Care REIT Inc
NASDAQ:SBRA
40.7
1 210%
0
US
National Health Investors Inc
NYSE:NHI
23.7
11%
2.1

See Also

Summary
VHP intrinsic value, competitors valuation, and company profile.
DCF Valuation
VHP stock valuation using Discount Cash Flow valuation method.
Relative Valuation
VHP stock valuation using valuation multiples.
Wall Street Estimates
VHP price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
VHP stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 210,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.